Fleury S.A. (BOVESPA:FLRY3) entered into a Share Purchase and Sale Agreement to acquire São Lucas Centro de Diagnosis for an Enterprise value of BRL 69.8 million on April 22, 2024. São Lucas' gross revenue reached BRL 47.1 million for the last 12 months ended September 30, 2023. The implied multiple for the Acquisition is 5.4x EV/EBITDA LTM.

The completion of the Acquisition is subject to certain conditions precedent. The Acquisition will not give rise to deliberations at the Company's Meeting nor will it confer the right to withdraw.